Healthcare · Biotechnology
Price
$0.77
Market Cap
$4.9M
Employees
1
Beta
0.12
Avg Volume
135,679
CEO
Ian Huen
Business Description
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa; and RPIDD, a liquid biopsy rapid pathogen diagnostic which is in preclinical trial to treat pathogen molecular diagnostics. The company also develops SACT-COV19, a repurposed small molecule which is in preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule which is in preclinical trial to treat bacterial infections caused by staphylococcus aureus, including methicillin-resistant staphylococcus aureus (MRSA); and ALS-2/3, a small molecule which is in preclinical trial for the treatment of gram+ve bacterial infections. In addition, it is developing NLS-1, which is in preclinical trial for the treatment of endometriosis; DLS-1+2, which is in preclinical trial to treat NSCLC with mutation; DLS-3, which is in preclinical trial to treat autoimmune disease; CLS-1, a macromolecule, which is in preclinical trial to treat obesity; and CLS-1 and CLS-3. Further, the company offers NativusWell DOI (NLS-2), a dietary supplement for women undergoing menopause; and provides management services. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Business History
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-4.07
Stock Price: $0.77
EPS (Diluted): -0.19
EPS (Diluted): -0.19
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.34
Stock Price: $0.77
Total Equity: $23.12M
Shares: 7,351,784
Total Equity: $23.12M
Shares: 7,351,784
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-4.28
Market Cap: $4.91M
Total Debt: $3.42M
Cash: $3.45M
EBITDA: -$1.82M
Total Debt: $3.42M
Cash: $3.45M
EBITDA: -$1.82M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$7.8M
Market Cap: $4.91M
Total Debt: $3.42M
Cash: $3.45M
Total Debt: $3.42M
Cash: $3.45M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.00
Stock Price: $0.77
Revenue: $0.00
Shares: 7,351,784
Revenue: $0.00
Shares: 7,351,784
EV/Sales (Total value vs revenue — works when P/E can't)
API0.00
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
0.0%
Gross Profit: $0.00
Revenue: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
0.0%
Operating Income: -$1.82M
Revenue: $0.00
Revenue: $0.00
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
0.0%
Net Income: -$1.36M
Revenue: $0.00
Revenue: $0.00
ROE (Profit from shareholder equity)
CALCNet Income / Total Equity
-5.9%
Net Income: -$1.36M
Total Equity: $23.12M
Total Equity: $23.12M
ROIC (Profit from all invested capital)
CALCNOPAT / Invested Capital
-7.9%
Operating Income: -$1.82M
Tax Rate: 0.0%
Equity: $23.12M
Total Debt: $3.42M
Cash: $3.45M
Tax Rate: 0.0%
Equity: $23.12M
Total Debt: $3.42M
Cash: $3.45M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
0.78
Current Assets: $3.59M
Current Liabilities: $4.59M
Current Liabilities: $4.59M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.15
Short-Term Debt: $3.42M
Long-Term Debt: $0.00
Total Debt: $3.42M
Total Equity: $23.12M
Long-Term Debt: $0.00
Total Debt: $3.42M
Total Equity: $23.12M
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 7,351,784
Shares: 7,351,784
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$3.14
Total Equity: $23.12M
Shares: 7,351,784
Shares: 7,351,784
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.25
Operating CF: -$1.84M
CapEx: $0.00
Shares: 7,351,784
CapEx: $0.00
Shares: 7,351,784
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $0.77
Stock Price: $0.77
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$1.36M
Net Income: -$1.36M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares APM against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 22, 2026 9:50pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.5M | $1.3M | $431,378 | $0 | $0 |
| Cost of Revenue | $1.5M | $1.2M | $420,812 | $255,046 | $0 |
| Gross Profit | $81,854 | $80,065 | $10,566 | $-255,000 | $0 |
| Operating Expenses | $19.3M | $17.3M | $10.6M | $3.5M | $1.8M |
| Operating Income | -$19.2M | -$17.5M | -$10.6M | -$3.8M | -$1.8M |
| Net Income | -$25.0M | -$9.8M | -$2.8M | -$4.3M | -$1.4M |
| EBITDA | -$25.8M | -$10.3M | -$9.5M | -$3.8M | -$1.8M |
| EPS | $-7.15 | $-2.75 | $-0.62 | $-0.78 | $-0.19 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 22, 2026 9:50pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $8.1M | $1.9M | $2.0M | $874,238 | $3.5M |
| Total Current Assets | $12.7M | $7.1M | $2.5M | $959,554 | $3.6M |
| Total Assets | $21.9M | $20.9M | $20.6M | $16.1M | $18.7M |
| Current Liabilities | $4.4M | $12.5M | $2.1M | $4.3M | $4.6M |
| Long-Term Debt | $0 | $500,000 | $3.1M | $0 | $0 |
| Total Liabilities | $4.4M | $13.0M | $5.3M | $4.4M | $4.9M |
| Total Equity | $23.6M | $15.7M | $24.8M | $21.1M | $23.1M |
| Retained Earnings | -$55.5M | -$65.3M | -$68.2M | -$72.4M | -$73.8M |
Cash Flow (Annual)
Last updated: Jun 22, 2026 9:50pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$14.7M | -$12.3M | -$7.7M | -$1.2M | -$1.8M |
| Capital Expenditure | $-137,776 | $-186,916 | $-3,010 | $-1 | $0 |
| Free Cash Flow | -$14.8M | -$12.5M | -$7.7M | -$1.2M | -$1.8M |
| Acquisitions (net) | $-113,830 | $0 | $15,385 | $58,621 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $4.6M | -$3.2M | -$3.0M | -$1.1M | $2.6M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 1:43am (7h ago)| Metric | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue |
$2.3M $2.3M – $2.3M
|
$31.2M $31.2M – $31.2M
|
$65.7M $65.7M – $65.7M
|
$106.8M $106.8M – $106.8M
|
| EBITDA |
$-459,999 $-459,999 – $-459,999
|
-$6.2M -$6.2M – -$6.2M
|
-$13.1M -$13.1M – -$13.1M
|
-$21.4M -$21.4M – -$21.4M
|
| Net Income |
-$28.9M -$28.9M – -$28.9M
|
-$5.1M -$5.1M – -$5.1M
|
$8.1M $8.1M – $8.1M
|
$22.8M $22.8M – $22.8M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 22, 2026 9:50pm (4d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -16.0% | -66.7% | -100.0% | — |
| Gross Profit Growth | -2.2% | -86.8% | -2,513.4% | +100.0% |
| Operating Income Growth | +8.8% | +39.5% | +64.2% | +52.1% |
| Net Income Growth | +60.9% | +71.2% | -51.1% | +68.1% |
| EBITDA Growth | +60.1% | +8.2% | +60.4% | +51.6% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for APM — it's generated by the pipeline (
market-narrative step).
No community reviews yet for APM.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30